A multicultural group practicing yoga together in a bright studio

Gala GLP-1 vs Sprout Health: GLP-1 Comparison 2026

Gala GLP-1 vs Sprout Health: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated October 6, 20264 min read

Quick answer

Gala GLP-1 and Sprout Health both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Gala GLP-1	Sprout Health
Best for	All-50-state compounded GLP-1 shoppers comparing cash-pay options	Balance of price and clinical support
Medication type	Compounded GLP-1 (semaglutide) and GLP-1/GIP, once-weekly at-home injection; microdosing option	Compounded semaglutide and tirzepatide; brand-name Wegovy/Zepbound listed cash-pay
Pricing model	Cash-pay subscription; recurring price advertised as a range across Gala’s own pages ($149–$199/mo)	12-month plan billed every 12 months, or a monthly plan billed every 4 weeks; Sprout states the same price at any dose (homepage, 2026-10-06)
Semaglutide price	Compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. Confirm the exact rate in enrollment.	From $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06)
Tirzepatide price	Compounded GLP-1/GIP, from $179/mo; microdosing GLP-1/GIP $149/mo (verified 2026-07-14). Confirm the exact rate in enrollment.	From $149/mo on the 12-month plan (billed $1,788 every 12 months); $199 per 4 weeks on the monthly plan; same price at any dose (compounded tirzepatide, homepage-verified 2026-10-06)
Key watchout	Gala lists a range rather than one recurring price: $179/mo 'all doses' in the hero, $199/mo 'with a 3-month plan' in the FAQ, and $149/mo for microdosing, confirm the exact ongoing rate in enrollment.	The $99 (semaglutide) and $149 (tirzepatide) figures are Sprout's 12-month plan rates, billed $1,188 and $1,788 every 12 months. The monthly plan is $149 (semaglutide) and $199 (tirzepatide) per 4 weeks, billed every 4 weeks, not per calendar month. Sprout states 'Same price at any dose.' Refund eligibility narrows once a provider has reviewed the intake (refund policy, read 2026-10-06).
Price checked	Checked by a person July 14, 2026 · an automated check re-read it October 15, 2026	Checked by a person October 6, 2026 · an automated check re-read it October 15, 2026

When to choose Gala GLP-1

You want compounded GLP-1 or GLP-1/GIP on a cash-pay plan available in all 50 states
You want a microdosing option ($149/mo)
You value an upfront 'not FDA-approved' compounding disclosure
You’re comfortable confirming the exact recurring rate in Gala’s enrollment flow

Check current Gala GLP-1 pricing →

When to choose Sprout Health

You want a low compounded entry price with provider visit, medication and shipping included
You want a stated flat price at every dose (Sprout's own homepage statement)
You're comfortable choosing between a 12-month plan billed every 12 months and a monthly plan billed every 4 weeks
You may want to escalate dose with the same provider over time

Check current Sprout Health pricing →

Full reviews

Frequently asked questions

Is Gala GLP-1 cheaper than Sprout Health?

Sprout Health starts lower on semaglutide (From $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06)). Sprout Health starts lower on tirzepatide (From $149/mo on the 12-month plan (billed $1,788 every 12 months); $199 per 4 weeks on the monthly plan; same price at any dose (compounded tirzepatide, homepage-verified 2026-10-06)). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Gala GLP-1 or Sprout Health?

Sprout Health starts lower on both semaglutide and tirzepatide based on listed entry pricing. That said, the right pick is the program whose support model and formulation match what you actually need.

Are Gala GLP-1 and Sprout Health compounded or brand-name?

Gala GLP-1 offers compounded glp-1 (semaglutide) and glp-1/gip, once-weekly at-home injection; microdosing option. Sprout Health offers compounded semaglutide and tirzepatide; brand-name wegovy/zepbound listed cash-pay. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Gala GLP-1 to Sprout Health?

Yes, switching between Gala GLP-1 and Sprout Health is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Gala GLP-1 and Sprout Health to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. Confirm the exact rate in enrollment. and $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06) are starting tiers, not your guaranteed long-term cost.